[Action of a decarboxylase inhibitor on endogenous plasmatic DOPA, in man].
D000284:Administration, Oral; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001386:Azides / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000494:pharmacology*; D002712:Chlorides; D004295:Dihydroxyphenylalanine / Q000096:biosynthesis / Q000097:blood*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D006900:Hydroxylation; D012694:Serine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001386:Azides; D001593:Benzyl Compounds; D002712:Chlorides; D004791:Enzyme Inhibitors; D006834:Hydrazines; D012694:Serine; D004295:Dihydroxyphenylalanine
Effet d'un inhibiteur de la décarboxylase sur la DOPA plasmatique endogène chez l'homme